e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Risk factors for allergic diseases in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Red Oil O staining compared to immunocytochemical staining for milk proteins of alveolar macrophages in chronic respiratory disease of infancy
F. De Baets, C. Aarts, F. Haerynck, S. Van daele, E. De Wachter, I. De Schutter, A. Malfroot, P. Schelstraete (Belgium; Nijmegen, Netherlands)
Source:
Annual Congress 2010 - Risk factors for allergic diseases in children
Session:
Risk factors for allergic diseases in children
Session type:
Thematic Poster Session
Number:
4766
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. De Baets, C. Aarts, F. Haerynck, S. Van daele, E. De Wachter, I. De Schutter, A. Malfroot, P. Schelstraete (Belgium; Nijmegen, Netherlands). Red Oil O staining compared to immunocytochemical staining for milk proteins of alveolar macrophages in chronic respiratory disease of infancy. Eur Respir J 2010; 36: Suppl. 54, 4766
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
The impact of anti-IgE treatment on the airway microbiome in asthma.
SCREENING FOR UNDERDIAGNOSED CHILDHOOD ASTHMA IN BATUMI (GEORGIA)
Related content which might interest you:
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Alveolar presence of red blood cells correlates with alveolar macrophage iron levels in COPD
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Lipid-laden alveolar macrophages quantitation as a marker of recurrent aspiration in children with chronic respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 380s
Year: 2002
Immunocytochemical detection of milk proteins in BAL fluid of children with recurrent respiratory symptoms with and without associated gastroesophageal reflux(GER)
Source: Eur Respir J 2004; 24: Suppl. 48, 612s
Year: 2004
Tryptase+ mast cells associate with fibrotic regions in the lungs of idiopathic pulmonary fibrosis patients; a multiplex staining approach
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Immunohistochemical staining in detection and localization of mycobacterial tuberculosis in human histological samples (preliminary report)
Source: Eur Respir J 2007; 30: Suppl. 51, 196s
Year: 2007
Immunofluorescense staining results in respiratory epithelial cells of patients with suspected PCD from Marmara University
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
Nitrotyrosine immunostaining and cellular inflammation in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
2D-DIGE on peripheral neutrophils of COPD: Annexin A1 high molecular weight complexes as markers for systemic inflammation in COPD
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
The use of immunohistochemical stains to identify Langerhans cells in pulmonary histiocytosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Utilisation of whole slide image analysis to quantify lesion formation, collagen content and cell density within histologically stained fibrotic lung tissue
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
A clinicopathological review of interstitial pneumonia with marked IgG
4
positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Immunohistochemical characterization of inflammatory cells in childhood bronchiolitis obliterans
Source: Eur Respir J 2001; 18: Suppl. 33, 292s
Year: 2001
Flow cytometry vs. immunohistochemistry in determining CD4+/CD8+ cell ratio in BAL fluid from patients with interstitial lung diseases
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Characterisation of guinea pig precision-cut lung slices: comparison with human tissues
Source: Eur Respir J 2006; 28: 603-611
Year: 2006
P-Smad2 and α-SMA are co-localized in fibroblastic foci of human idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Altered expression of immune cells surface markers of children with recurrent infections of respiratory tract
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005
Increased numbers of airway wall plasma cells in smokers with chronic bronchitis: co-localization and gene expression for interleukin 4 and 5
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002
Circulating inflammatory proteins and red blood cells antioxidant activity in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 537s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept